Week In Review: China Life Science Books $1 Billion In Ten Announced Deals

Sino Biopharm announced a deal worth up to $200 million to acquire a 60% stake in Softhale, a Belgium company. Brii Biosciences, a Shanghai-US company developing anti-infectives and CNS products for China, completed a $155 million Series C financing.